FDA Drug recall D-1132-2015
MD-Gastroview (Diatrizoate Meglumine and Diatrizoate Sodium Solution USP)
- FDA Drug
- Class II
- terminated
- Published 2015-06-17
On 2015-06-17 the FDA classified a Class II recall of MD-Gastroview (Diatrizoate Meglumine and Diatrizoate Sodium Solution USP) by Mallinckrodt, citing labeling: incorrect or missing lot number and/or expiration date.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1132-2015 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2015-05-15 |
| Published | 2015-06-17 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Mallinckrodt |
| Distribution | n/a |
Product
MD-Gastroview (Diatrizoate Meglumine and Diatrizoate Sodium Solution USP); 37% Organically Bound Iodine For Gastrointestinal Radiography; Oral or rectal use only; Rx only; 30 mL; Single-Unit Container; ; Mallinckrodt Inc., St. Louis, MO 63042. NDC 0019-4816-04
Reason
Labeling: incorrect or missing lot number and/or expiration date
Identifiers
| ndc | 0019-4816-04 |
|---|---|
| code_info | Lot #: B201B, Exp April 2015; B346D, Exp August 2015. |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1132-2015%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.